Exploring parental cystic fibrosis disclosure to well children

Amanda Boyer1, Karen Raraigh2, Stephanie Riley3

  • 1University of Maryland School of Medicine, Baltimore, Maryland, USA.

Insights

Parents of children with cystic fibrosis (CF) openly discuss medical aspects of the disease with well siblings, starting around age five. Parental knowledge of CF did not influence disclosure topics with healthy children.

Area of Science:

  • Genetics
  • Pediatrics
  • Psychology

Background:

  • Cystic fibrosis (CF) is a chronic genetic illness impacting multiple organ systems.
  • Disclosure of a sibling's CF diagnosis to well children is understudied.
  • The relationship between parental CF knowledge and disclosure practices is unevaluated.

Purpose of the Study:

  • Assess parental understanding of CF.
  • Identify common topics and discussion frequency regarding CF with well children.
  • Examine associations between parental CF knowledge and disclosure aspects.

Main Methods:

  • Anonymous online survey distributed through CF support organizations.
  • Participants: parents with at least one child with CF and one without.
  • Data collected on disclosure timing, topics, and parental CF knowledge.

Main Results:

  • Disclosure typically begins around 5.4 years old.
  • Medical concerns and treatment were the most frequently discussed and important topics.
  • Financial impact was discussed by fewer parents and ranked as least important.
  • Parents demonstrated high CF knowledge (mean score 8.9/10).
  • No associations found between parental knowledge, education, income, and disclosure topics.

Conclusions:

  • Parents are knowledgeable about CF and prioritize discussing medical aspects with well siblings.
  • Parental CF knowledge does not appear to influence the topics disclosed to well children.
  • Findings can inform healthcare professionals assisting families with disclosure strategies.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
324
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
210
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
102.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
384